Today, Peter Hodson and Stockchase Discover commented about whether ITP-T, CSH.UN-T, ACI-N, WMK-N, PINS-N, NVDA-Q, PLTR-Q, COST-Q, AMZN-Q, BNS-T, WCP-T, BEI.UN-T, CJT-T, VMD-T, DWS-X, CAE-T, LSPD-T, KXS-T, MG-T, GSY-T, STC-T, GOOS-T, KEY-T are stocks to buy or sell.
He didn't like it for a while, but now more than before. The telehealth space is getting crowded and they've had issues with CMS code. It's a good American company, though doesn't receive much attention here. VMS is merely okay. He prefers other names like Knight Therapeutics. It's a decent, second-tier company.